September 24, 2025 - 13:01

The EU-funded HYScale project has unveiled significant technical breakthroughs that enhance the cost competitiveness and scalability of green hydrogen production. These advancements focus on improving electrolysis technology, which is crucial for converting renewable energy into hydrogen fuel. By leveraging innovative methods and materials, the project aims to reduce the costs associated with hydrogen production, making it a more viable alternative to fossil fuels.
The breakthroughs are expected to facilitate the large-scale deployment of green hydrogen across various sectors, including transportation, energy storage, and industrial processes. As countries strive to meet their climate goals, the ability to produce hydrogen sustainably and affordably is paramount. The HYScale project is poised to play a vital role in the transition to a low-carbon economy by enabling widespread adoption of hydrogen as a clean energy source.
With ongoing research and development, the future of green hydrogen looks promising, potentially transforming the energy landscape and contributing significantly to global efforts in combating climate change.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...